NH Narayana Hrudayalaya Q1 FY26 results (Apr–Jun 2025) and concall
Narayana Hrudayalaya reported Q1 FY26 earnings with strong ramp-up in its Integrated Care and Insurance businesses, though the former is currently loss-making. The company saw improved ARPP and continued growth in oncology, targeting 20-25% of revenue in five years. However, new hospital commissioning is expected to impact margins, and greenfield capex is slightly behind schedule. Management addressed concerns about Cayman volatility and administrative cost increases, while also highlighting ongoing digitalization efforts.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 |
|---|---|---|---|---|
| Revenue | 1,367 | 1,335 | 1,475 | 1,507 |
| EBITDA | 309 | 307 | 358 | 337 |
| Net profit | 199 | 193 | 197 | 197 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
